rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2007-10-23
|
pubmed:abstractText |
Mucous membrane pemphigoid (MMP) is a mucocutaneous vesiculobullous autoimmune disease characterized by autoantibodies to components of the basement membrane zone (BMZ). Recently, it has been reported that patients with MMP who have autoantibodies to laminin 5, known as anti-epiligrin cicatricial pemphigoid (AECP) have a high incidence of malignancy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0307-6938
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
637-41
|
pubmed:meshHeading |
pubmed-meshheading:17524068-Adult,
pubmed-meshheading:17524068-Aged,
pubmed-meshheading:17524068-Aged, 80 and over,
pubmed-meshheading:17524068-Autoantibodies,
pubmed-meshheading:17524068-Autoimmune Diseases,
pubmed-meshheading:17524068-Biological Markers,
pubmed-meshheading:17524068-Cell Adhesion Molecules,
pubmed-meshheading:17524068-Eye Diseases,
pubmed-meshheading:17524068-Female,
pubmed-meshheading:17524068-Follow-Up Studies,
pubmed-meshheading:17524068-Humans,
pubmed-meshheading:17524068-Integrin beta4,
pubmed-meshheading:17524068-Male,
pubmed-meshheading:17524068-Middle Aged,
pubmed-meshheading:17524068-Neoplasms,
pubmed-meshheading:17524068-Pemphigoid, Benign Mucous Membrane,
pubmed-meshheading:17524068-Prognosis,
pubmed-meshheading:17524068-Risk Assessment
|
pubmed:year |
2007
|
pubmed:articleTitle |
Relative risk for cancer in mucous membrane pemphigoid associated with antibodies to the beta4 integrin subunit.
|
pubmed:affiliation |
Immunology Service, Massachusetts Eye and Ear Infirmary, Medical School, Boston, MA, USA.
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|